Insider Trading Activity FibroGen, Inc (NASDAQ:FGEN) – VP Sold 95,000 shares of Stock

ME Staff

7 years ago

Insider Trading Activity For FibroGen, Inc (NASDAQ:FGEN)

Pat Cotroneo , VP of FibroGen, Inc (NASDAQ:FGEN) reportedly Sold 95,000 shares of the company’s stock at an average price of 50.61 for a total transaction amount of $4,807,950.00 SEC Form

Insider Trading History For FibroGen, Inc (NASDAQ:FGEN)

On 6/25/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $23.57 per share and the total transaction amounting to $636,390.00.View SEC Filing

On 7/6/2015 K Peony Yu, VP, sold 5,381 with an average share price of $22.69 per share and the total transaction amounting to $122,094.89.View SEC Filing

On 7/9/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $22.11 per share and the total transaction amounting to $596,970.00.View SEC Filing

On 7/20/2015 Pat Cotroneo, CFO, sold 7,881 with an average share price of $23.47 per share and the total transaction amounting to $184,967.07.View SEC Filing

On 7/20/2015 Frank H Md Valone, Insider, sold 1,000 with an average share price of $23.70 per share and the total transaction amounting to $23,700.00.View SEC Filing

On 7/23/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $24.71 per share and the total transaction amounting to $667,170.00.View SEC Filing

On 9/1/2015 Frank H. Md Valone, insider, sold 10,000 with an average share price of $23.58 per share and the total transaction amounting to $235,800.00.View SEC Filing

Analyst Ratings For FibroGen, Inc (NASDAQ:FGEN)
These are 1 Hold Rating, 5 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for FibroGen, Inc (NASDAQ:FGEN) is Buy (Score: 3.00) with a consensus target price of $66.60 , a potential (62.04% upside)

Analyst Ratings History For FibroGen, Inc (NASDAQ:FGEN)

On 9/23/2015 Lake Street Capital Initiated Coverage of rating Hold with a price target of $25.00
On 8/9/2016 Credit Suisse Group Reiterated Rating Buy with a price target of $37.00
On 1/18/2017 Royal Bank Of Canada Reiterated Rating Buy
On 7/21/2017 Goldman Sachs Group, Inc. (The) Downgraded rating Buy to Neutral with a price target of $31.00
On 8/8/2017 Stifel Nicolaus Boost Price Target of rating Buy to Buy with a price target of $38.00 to $80.00
On 8/8/2017 Jefferies Group LLC Reiterated Rating Positive to Buy with a price target of $75.00 to $75.00
On 8/8/2017 Citigroup Inc Boost Price Target of rating Top Pick with a price target of $48.00 to $65.00

Recent Trading Activity for FibroGen, Inc (NASDAQ:FGEN)
Shares of FibroGen, Inc closed the previous trading session at 41.10 down -2.55 -5.84% with 1,226,276 shares trading hands.